Heterogeneity of dementia with Lewy bodies: Insights from clinical presentations, neuropathology, and biomarkers
Overall, the paper explores the complexity of DLB's heterogeneous nature, advocating for deeper exploration of its diverse pathological pathways, genetic predispositions, and clinical profiles to improve diagnosis and treatment outcomes. Understanding this heterogeneity is crucial for the development of personalized therapeutic strategies and effective management of the disease.
Authors
- Ariane Bollack (ORCID: https://orcid.org/0000-0002-9169-7530)
- Zulfiqar Haider Sheikh (ORCID: https://orcid.org/0000-0001-6613-6638)
- Matteo Pardini (ORCID: https://orcid.org/0000-0002-4740-1982)
- Gill Farrar (ORCID: https://orcid.org/0000-0002-0726-723X)
- Silvia Daniela Morbelli (ORCID: https://orcid.org/0000-0002-7833-6095)
- Beatrice Orso (ORCID: https://orcid.org/0000-0001-9983-7940)
Institutions
- General Electric (Spain) (ES)
- Azienda Ospedaliera Citta' della Salute e della Scienza di Torino (IT)
- Ospedale Policlinico San Martino (IT)
- University College London (GB)
- University of Turin (IT)
- University of Genoa (IT)
Publication Details
- Journal
- Neurological Sciences
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1007/s10072-025-08725-3
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00